Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Topical oral thymoxamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Coronary vasodilator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Sodium nitroprusside 25mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Diazoxide 15mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing precisely diazoxide 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Endothelin receptor antagonist |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Human B-type natriuretic peptide |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Treprostinil sodium (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Isosorbide (substance) |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Amyl nitrite (substance) |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Hydralazine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Minoxidil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Prenylamine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Cyclandelate (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Nimodipine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Nicorandil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Oxerutins (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Naftidrofuryl |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing tolazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing diazoxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Medicinal product acting as vasodilator (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing nitroprusside (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Poisoning by nitrite |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Tolazoline (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
monosulfate de guanéthidine 10 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate 3% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate 1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole 50mg/5ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing guanethidine monosulfate and hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Diazoxide 15mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanethidine monosulfate+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Adverse reaction to coronary vasodilators NOS |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Adverse reaction to other vasodilators |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Adverse reaction to vasodilators NOS |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing precisely dipyridamole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Fenoldopam |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Xanthine |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Flosequinan (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Inositol nicotinate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Xanthinol |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Alpha adrenergic receptor antagonist |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Aminophylline (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Sodium nitroprusside (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Dipyridamole (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Betahistine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
[X]Coronary vasodilators causing adverse effects in therapeutic use, not elsewhere classified |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Accidental diazoxide poisoning (disorder) |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Intentional diazoxide poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Accidental nitrite poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Intentional nitrite poisoning |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Ranolazine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Aviptadil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Nesiritide (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Nitroprusside (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Levosimendan (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Allergy to vasodilator |
Causative agent (attribute) |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
Molsidomine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Adverse reaction to coronary vasodilator |
Causative agent (attribute) |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
Dihydralazine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Trimetazidine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Hexobendine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Riociguat (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing treprostinil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Treprostinil 600 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Human B-type natriuretic peptide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing guanethidine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Product containing epinephrine and guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Selexipag (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Treprostinil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Sodium nitroprusside dihydrate (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Aminophylline anhydrous |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Aminophylline hydrate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Betahistine mesilate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Guanadrel sulfate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Moxisylyte hydrochloride (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Labetalol (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Indoramin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Prazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Alfuzosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Yohimbine hydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Atipamezole (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Doxazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Yohimbine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Urapidil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Moxisylyte |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Azapetine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Terazosin hydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
Terazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|